CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Launched by RUSSIAN SOCIETY OF COLORECTAL SURGEONS · Nov 1, 2023

Keywords

ClinConnect Summary

The SPACE trial is studying two different methods for examining colon cancer samples to see which one is more accurate. The European method mainly relies on pathologists, who are doctors that examine tissue samples, while the Japanese method involves surgeons who help collect and assess the samples. This study aims to find out if the Japanese method is less accurate than the European one, as there hasn’t been enough research to confirm its effectiveness.

To be eligible for this trial, participants must be diagnosed with colon cancer and have had surgery to remove part of their colon (a procedure called colectomy). They also need to have a specific type of cancer called adenocarcinoma and agree to join the study. Unfortunately, individuals with rectal cancer or those who didn’t have surgery for their colon cancer cannot participate. If you choose to join the trial, you will help researchers learn more about these examination methods, which could lead to better diagnosis and treatment for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed with colon cancer who underwent colectomy;
• • Patients with pathological confirmed adenocarcinoma;
• • Patients agreed to participate in the study.
• Exclusion Criteria:
• • Patients suffered from rectal cancer;
• • Patients diagnosed with colon cancer but did not undergo colectomy;
• • Patients refused participation.